SCHEMBL13428405

SCHEMBL13428405

C1=Cc2ccccc2N(c2ccc3c(-c4cc5ccccc5c5ccccc45)c4cc(N5c6ccccc6C=Cc6ccccc65)ccc4c(-c4cc5ccccc5c5ccccc45)c3c2)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
HIF1A Q16665 3/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP2D6 P10635 1/20 0.34
ALOX12 P18054 1/20 0.34
KMT2A Q03164 1/20 0.34
SOS1 Q07889 1/20 0.33
POLB P06746 1/20 0.33
P2RX4 Q99571 1/20 0.32
HSD17B10 Q99714 2/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428447 0.91 GPR84 (0.34) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13456449 0.90 HSP90AA1 (0.33) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL12928337 0.86 POLB (0.42) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13540425 0.85
SCHEMBL13427524 0.83 CYP11B1 (0.34) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13427114 0.82 BCHE (0.41) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13427232 0.82 MAPT (0.33) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13009014 0.82 ALDH1A1 (0.34) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13426901 0.82 HPGD (0.35) ALDH1A1HIF1AHPGDMAPK1CYP1A2
SCHEMBL13009197 0.81 POLB (0.38) ALDH1A1HPGDMAPK1MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A ALDH1A1 1477/4885HIF1A 3916/4885HPGD 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.